| Literature DB >> 32305497 |
Gerasimos Siasos1, Evanthia Bletsa2, Panagiota K Stampouloglou2, Evangelos Oikonomou2, Vasiliki Tsigkou2, Stavroula A Paschou2, Konstantinos Vlasis3, Georgios Marinos2, Manolis Vavuranakis2, Christodoulos Stefanadis2, Dimitris Tousoulis2.
Abstract
Cardiovascular disease (CVD) remains the predominant cause of human morbidity and mortality in developed countries. Currently, microRNAs have been investigated in many diseases as well-promising biomarkers for diagnosis, prognosis, and disease monitoring. Plenty studies have been designed so as to elucidate the properties of microRNAs in the classification and risk stratification of patients with CVD and also to evaluate their potentials in individualized management and guide treatment decisions. Therefore, in this review article, we aimed to present the most recent data concerning the role of microRNAs as potential novel biomarkers for cardiovascular disease.Entities:
Keywords: Atherosclerosis; Biomarkers; Cardiovascular disease; MicroRNAs; Molecular cardiology
Year: 2020 PMID： 32305497 DOI： 10.1016/j.hjc.2020.03.003
Source DB: PubMed Journal: Hellenic J Cardiol ISSN： 1109-9666